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Implications for 
Nursing Care
Aortic Stenosis
Danielle Ridgway, BSN, RN, CCRN, SRNA
Introduction
• Aortic stenosis (AS) is a condition 
where the opening of the aortic 
valve becomes narrower.  The 
narrowing causes a resistance in 
blood flow from the left ventricle 
(LV) to the aorta, which results in a 
reduction of flow and higher 
pressures within the left ventricle
(McCance & Huether, 2014).
• AS affects about 2% of adults over 
the age of 65 (McCance & Huether, 
2014).
• The most common heart valve 
disorder in Europe and North 
America is AS due to calcification 
(Wald, Williams, Bangash, & 
Bestwick, 2018).
References
Bhattacharyya, S., Mittal, T., Abayalingam, M., Kabir, 
T., Dalby, M., Cleland, J. G., . . . Rahman Haley, S. 
(2016). Classification of aortic stenosis by flow 
and gradient patterns provides insights into the 
pathophysiology of disease. Angiology, 67(7), 
664-669. doi:10.1177/0003319715611804
Cary, T., & Pearce, J. (2013). Aortic stenosis: 
Pathophysiology, diagnosis, and medical 
management of nonsurgical patients. Critical Care 
Nurse, 33(2), 58-72. doi:10.4037/ccn2013820
Estes, B. A., & Kalra, A. (2018). Contemporary 
nursing care in transcatheter aortic valve 
replacement. Journal of Vascular Nursing, 36(4), 
186-188. doi:10.1016/j.jvn.2018.08.001
Hines, R. L., & Marschall, K. E. (2018). Stoelting's
anesthesia and co-existing disease (7th ed.). 
Philadelphia, PA: Elsevier.
Joseph, J., Naqvi, S. Y., Giri, J., & Goldberg, S. (2017). 
Aortic stenosis: Pathophysiology, diagnosis, and 
therapy.The American Journal of 
Medicine, 130(3), 253-263. 
doi:10.1016/j.amjmed.2016.10.005
Kanwar, A., Thaden, J. J., & Nkomo, V. T. (2018). 
Management of patients with aortic valve 
stenosis. Mayo Clinic Proceedings, 93(4), 488-508. 
doi:10.1016/j.mayocp.2018.01.020
McCance, K. L., & Huether, S. E. (eds.). (2014). 
Pathophysiology: The biologic basis for disease in 
adults and children (7th ed.). St. Louis, MO: 
Elsevier/Mosby.
Toyota, K., Ota, T., Nagamine, K., Koide, Y., Nomura, 
T., Yamanaka, F., . . . Saito, S. (2016). Effect of 
transcatheter aortic valve implantation on 
intraoperative left ventricular end-diastolic 
pressure. Journal of Anesthesia, 30(6), 1051-
1055. doi:10.1007/s00540-016-2229-7
Wald, D. S., Williams, S., Bangash, F., & Bestwick, J. 
P. (2018). Watchful waiting in aortic stenosis: The 
problem of acute decompensation. American 
Journal of Medicine, 131(2), 173-177. 
doi:10.1016/j.amjmed.2017.08.027
Yurek, L. A., Jakub, K. E., & Menacho, M. M. (2015). 
Severe symptomatic aortic stenosis in older 
adults pathophysiology, clinical manifestations, 
treatment guidelines, and transcatheter aortic 
valve replacement (TAVR). Journal of 
Gerontological Nursing, 41(6), 8-13. 
doi:10.3928/00989134-20150414-02
Significance of 
Pathophysiology • It is anticipated that the prevalence 
of AS will double in the next 20 years 
(Hines & Marschall, 2018).  Health 
care providers need to make 
understanding the pathophysiological 
processes, clinical manifestations, 
symptoms associated with the 
disease progression, treatment 
options, and nursing implications a 
priority.
• Proper management of patients with 
AS requires an understanding of the 
criteria used to define the disease 
severity (Joseph et al., 2017).
• With an increase in TAVR procedures 
for AS, nurses must expand their 
knowledge and scope to care for 
these patients.  Better understanding
of the procedure and possible
complications leads to better nursing 
care and patient outcomes (Estes & 
Kalra, 2018).
• Early recognition and management of 
AS is of utmost importance because 
untreated symptomatic severe 
disease is universally fatal (Kanwar, 
Thaden & Nkomo, 2018).
• It is critical for nursing care to evolve 
and grow in tandem with the 
increased TAVR population to 
integrate the complex care of these 
patients to provide optimal care and 
improve patient outcomes (Estes & 
Kalra, 2018).
• Hypertrophy increases myocardial 
oxygen demand and could lead to 
ischemia, dysrhythmias, myocardial 
infarction, and heart failure (McCance 
& Huether, 2014).
• AS is characterized by a relatively 
benign course in patients with 
asymptomatic disease but a rapid 
downhill course with the onset of 
symptoms (Kanwar, Thaden & Nkomo, 
2018).
• AS holds a poor survival rate unless 
timely valve replacement is performed 
(Kanwar, Thaden & Nkomo, 2018).
• In the perioperative setting, patients 
with aortic stenosis are at high risk of 
experiencing cardiac complications.  
Safe administration of anesthesia 
requires prevention of any 
hemodynamic change that decreases 
cardiac output (Hines & Marschall, 
2018).
• Cardiopulmonary resuscitation is 
typically ineffective in patients with 
aortic stenosis; thus, education on the 
disease and perioperative treatment is 
extremely important for nurse 
anesthetists (Hines & Marschall, 2018).
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Conclusions
Treatment
• About 39% of patients admitted with 
acute decompensation have no prior 
diagnosis, highlighting the need for 
increased identification of aortic 
stenosis (Wald et al., 2018).  Nurses 
should incorporate assessment of AS 
signs and symptoms into their routine 
care; especially patients complaining 
of reduced exercise capacity.
• Teaching patients with AS to 
recognize and immediately report 
symptoms associated with the 
disease progression can reduce 
subjective denial of symptoms, time 
to treatment, and mortality (Yurek, 
Jakub & Menacho, 2015).
• Hospitalization with acute 
decompensation is an overlooked and 
life-threatening problem in patients 
with AS (Wald et al., 2018).  Nurses 
need to be hyperaware of the 
hemodynamic status of patients with 
AS.
• Medication compliance following 
valve replacement is vital to 
successful recovery and maintenance.  
Medication education for the patient 
and family members is very
important.  As some medications can 
be expensive, nursing should consult 
case management for assistance to 
help ensure patient compliance (Estes 
& Kalra, 2018).
Pathophysiology
• Narrowing of the aortic valve is 
generally due to three main causes: 
1) Age associated calcification, 2) 
congenital bicuspid aortic valve and 
3) Inflammation associated with 
rheumatic heart disease (McCance & 
Huether, 2014).
• Age associated AS is the end result of 
an inflammatory process caused by 
endothelial damage due to 
mechanical stress, lipid penetration 
leading to fibrosis, leaflet thickening, 
and finally calcification (Joseph, 
Naqvi, Giri, & Goldberg, 2017).
• In AS from all causes, the opening of 
the aortic valve narrows, causing 
diminished blood flow from the LV to 
the aorta (McCance & Huether, 
2014).
• Pressure in the LV rises to overcome 
the outflow obstruction caused by 
the narrow valve, in an attempt to 
preserve stroke volume and cardiac 
output.  LV hypertrophy develops 
due to an increased workload to get 
blood across the valve (Yurek, Jakub 
& Menacho, 2015).
• Increased jet velocity and mean 
pressure gradient develop across the 
valve, with decreasing valve area 
throughout progression of the 
disease.  AS is generally graded as 
mild, moderate, or severe; and the 
grading determines the frequency of 
echocardiogram monitoring (Yurek, 
Jakub & Menacho, 2015).
AS Severity Grading
Table	1.	Classification	of	Progressive	Aortic	Stenosis	and	Frequency	of	
Echocardiogram	Monitoring	(Yurek,	Jakub	&	Menacho,	2015)
Importance
• AS is increasing in prevalence due to 
aging of the population and 
increased life expectancy (Kanwar, 
Thaden & Nkomo, 2018).
• Cardiac surgical intensive care unit 
(CVICU) nurses and certified 
registered nurse anesthetists 
(CRNA’s) provide care to many 
patients with AS.  
• Proper education of the underlying
pathology and its significance, 
symptoms,  and appropriate 
diagnosis and treatment is essential 
to provide high level nursing care.
Signs and 
Symptoms
Classic Triad  (Joseph, Naqvi, Giri, and 
Goldberg, 2017)
1. Heart Failure or exercise 
intolerance 
2. Syncope
3. Exertion related angina
Kanwar, Thaden, and Nkomo (2018) 
described the following additional 
symptoms:
• Dyspnea occurs due to increased LV 
filling pressure or the inability to 
increase cardiac output during 
exercise
• Dizziness or syncope results from a
reduction in cerebral perfusion  
• Vague symptoms of tiredness or 
fatigue 
Medical Management
• There is no effective pharmacologic treatment for AS (Joseph et al., 2017).
Balloon Valvuloplasty 
• A balloon is placed across the stenotic valve and inflated/deflated several times to 
widen the valve area (Cary & Pearce, 2013)
• Used in patients who are not able to receive an aortic valve replacement due to 
comorbidities (Joseph et al., 2017).
• Can be used as a bridge to SAVR or TAVR in unstable patients with high surgical risk, 
but does not alter the pathology.  The hemodynamic benefit lasts for only about 6 
months.  The chances of restenosis are high (Joseph et al., 2017).
Valve Replacement 
• Aortic valve replacement is recommended in symptomatic patients with severe AS 
(Bhattacharyya et al., 2016)
• Standard treatments of severe AS are surgical aortic valve replacement (SAVR) and 
transcatheter aortic valve replacement (TAVR) (Joseph et al., 2017).
SAVR TAVR
• Through open heart surgery, the aortic
valve is removed and a new valve is
sewn into the orifice (Cary & Pearce, 
2013).
• Considered the gold standard
treatment of severe AS and performed 
with either mechanical or bioprosthetic 
valves.
• Surgical risk is calculated using the
Society of Thoracic Surgeons (STS)
score.  Patients are classified as being 
high surgical risk if STS score > 8%, or if 
they have coexisting noncardiac 
conditions that predict poor survival.  
• As compared with TAVR, the risk of 
major bleeding and new-onset atrial 
fibrillation are higher; however, the risk 
of a major stroke and a major vascular
complications is less.
(Joseph et al., 2017)
• The replacement valve is located inside 
a stent that is deployed over the 
diseased valve via a transcatheter 
approach (Cary & Pearce, 2013).
• Indicated for inoperable, high-risk, and 
intermediate-risk surgical patients as 
an alternative to SAVR.
• Less invasive as compared with SAVR
• Commonly performed in a hybrid
operative room under general
anesthesia, but can also be performed 
in the cardiac catheterization lab under 
conscious sedation.
• The most common approach for 
implantation is  transfemoral (TF).
• Complications associated with TAVR 
include stroke, vascular access-site 
bleeding, paravalvular leak, and heart 
block requiring permanent pacing.
(Estes & Kalra, 2018)
Figure	1.		Summary	of	pathological	processes	occurring	within	the	valve	during	
AS		(Hines &	Marschall,	2018).
Table 2.		Hemodynamic	Parameters	and	the	Effects	of	Aortic	Stenosis	(Cary	&	
Pearce,	2013).
Hemodynamics
